Seven Fleet Capital Management as of Dec. 31, 2025
Portfolio Holdings for Seven Fleet Capital Management
Seven Fleet Capital Management holds 85 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 42.6 | $63M | 1.5M | 41.52 | |
| Cogent Biosciences (COGT) | 5.1 | $7.6M | 214k | 35.52 | |
| Soleno Therapeutics (SLNO) | 4.1 | $6.0M | 130k | 46.30 | |
| Terns Pharmaceuticals (TERN) | 3.6 | $5.3M | 130k | 40.40 | |
| Revolution Medicines (RVMD) | 3.5 | $5.2M | 66k | 79.65 | |
| Liquidia Corporation Com New (LQDA) | 2.1 | $3.1M | 91k | 34.49 | |
| Compass Therapeutics (CMPX) | 2.1 | $3.1M | 569k | 5.37 | |
| Exelixis (EXEL) | 2.0 | $3.0M | 69k | 43.83 | |
| Assembly Biosciences Com New (ASMB) | 1.7 | $2.5M | 74k | 34.01 | |
| Axsome Therapeutics (AXSM) | 1.6 | $2.4M | 13k | 182.64 | |
| Tyra Biosciences (TYRA) | 1.4 | $2.1M | 80k | 26.29 | |
| Tango Therapeutics (TNGX) | 1.3 | $1.9M | 215k | 8.86 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.2 | $1.8M | 14k | 134.85 | |
| Xencor (XNCR) | 1.1 | $1.7M | 110k | 15.31 | |
| Enliven Therapeutics (ELVN) | 1.0 | $1.5M | 100k | 15.40 | |
| Pharvaris N V (PHVS) | 1.0 | $1.5M | 55k | 27.75 | |
| Mineralys Therapeutics (MLYS) | 1.0 | $1.5M | 42k | 36.29 | |
| Belite Bio Sponsored Ads (BLTE) | 1.0 | $1.5M | 9.2k | 159.96 | |
| Dyne Therapeutics (DYN) | 0.9 | $1.4M | 70k | 19.56 | |
| Nuvalent Inc-a (NUVL) | 0.9 | $1.3M | 13k | 100.59 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $1.2M | 5.7k | 213.24 | |
| Amicus Therapeutics (FOLD) | 0.8 | $1.2M | 83k | 14.24 | |
| Vaxcyte (PCVX) | 0.8 | $1.2M | 25k | 46.14 | |
| Avalo Therapeutics Com New (AVTX) | 0.8 | $1.2M | 63k | 18.16 | |
| Inhibikase Therapeutics Com New (IKT) | 0.7 | $1.1M | 534k | 2.05 | |
| Madrigal Pharmaceuticals (MDGL) | 0.7 | $1.1M | 1.9k | 582.34 | |
| Geron Corporation (GERN) | 0.7 | $1.0M | 778k | 1.32 | |
| Krystal Biotech (KRYS) | 0.7 | $986k | 4.0k | 246.54 | |
| Athira Pharma | 0.7 | $969k | 128k | 7.57 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.6 | $920k | 167k | 5.50 | |
| Silence Therapeutics Ads (SLN) | 0.6 | $897k | 148k | 6.08 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.6 | $873k | 167k | 5.24 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $864k | 32k | 27.22 | |
| Celcuity (CELC) | 0.6 | $832k | 8.3k | 99.74 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.5 | $796k | 2.7k | 294.74 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $782k | 48k | 16.15 | |
| Palisade Bio (PALI) | 0.5 | $770k | 328k | 2.35 | |
| Relmada Therapeutics (RLMD) | 0.5 | $744k | 154k | 4.83 | |
| Protagonist Therapeutics (PTGX) | 0.5 | $699k | 8.0k | 87.34 | |
| Cidara Therapeutics Com New (CDTX) | 0.5 | $668k | 3.0k | 220.89 | |
| Cytokinetics Com New (CYTK) | 0.4 | $657k | 10k | 63.54 | |
| Nektar Therapeutics Com New (NKTR) | 0.4 | $634k | 15k | 42.28 | |
| United Therapeutics Corporation (UTHR) | 0.4 | $633k | 1.3k | 487.25 | |
| Relay Therapeutics (RLAY) | 0.4 | $618k | 73k | 8.46 | |
| Dianthus Therapeutics (DNTH) | 0.4 | $604k | 15k | 41.21 | |
| Mbx Biosciences (MBX) | 0.4 | $574k | 18k | 31.54 | |
| Evolus (EOLS) | 0.4 | $545k | 82k | 6.65 | |
| Zymeworks Del (ZYME) | 0.4 | $542k | 21k | 26.33 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.3 | $462k | 57k | 8.14 | |
| Miragen Therapeutics (VRDN) | 0.3 | $456k | 15k | 31.12 | |
| Prothena Corp SHS (PRTA) | 0.3 | $414k | 43k | 9.55 | |
| Nurix Therapeutics (NRIX) | 0.3 | $379k | 20k | 18.97 | |
| Savara (SVRA) | 0.3 | $379k | 63k | 6.03 | |
| Tarsus Pharmaceuticals (TARS) | 0.2 | $369k | 4.5k | 81.88 | |
| Pliant Therapeutics (PLRX) | 0.2 | $337k | 277k | 1.22 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $323k | 107k | 3.01 | |
| Septerna (SEPN) | 0.2 | $319k | 11k | 27.88 | |
| Eliem Therapeutics (CLYM) | 0.2 | $306k | 76k | 4.00 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $276k | 40k | 6.90 | |
| Beam Therapeutics (BEAM) | 0.2 | $264k | 9.5k | 27.72 | |
| Entera Bio SHS (ENTX) | 0.2 | $263k | 135k | 1.94 | |
| Viking Therapeutics (VKTX) | 0.1 | $211k | 6.0k | 35.18 | |
| Uniqure Nv SHS (QURE) | 0.1 | $209k | 8.7k | 23.93 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $208k | 49k | 4.26 | |
| Ocular Therapeutix (OCUL) | 0.1 | $208k | 17k | 12.14 | |
| Oruka Therapeutics (ORKA) | 0.1 | $159k | 5.2k | 30.31 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.1 | $140k | 4.0k | 35.08 | |
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $140k | 12k | 12.08 | |
| Apogee Therapeutics (APGE) | 0.1 | $136k | 1.8k | 75.48 | |
| Alx Oncology Hldgs (ALXO) | 0.1 | $133k | 118k | 1.13 | |
| Verastem Com New (VSTM) | 0.1 | $117k | 15k | 7.72 | |
| Regencell Bioscience Hldgs L Ordinary Shares (RGC) | 0.1 | $92k | 4.4k | 21.00 | |
| Trevi Therapeutics (TRVI) | 0.1 | $89k | 7.1k | 12.52 | |
| Immunic (IMUX) | 0.1 | $83k | 155k | 0.53 | |
| Pmv Pharmaceuticals (PMVP) | 0.1 | $79k | 64k | 1.25 | |
| Monte Rosa Therapeutics (GLUE) | 0.0 | $63k | 4.0k | 15.68 | |
| Traws Pharma Com New (TRAW) | 0.0 | $56k | 49k | 1.13 | |
| Astria Therapeutics | 0.0 | $52k | 4.0k | 13.09 | |
| Edgewise Therapeutics (EWTX) | 0.0 | $50k | 2.0k | 24.82 | |
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $42k | 63k | 0.66 | |
| Enanta Pharmaceuticals (ENTA) | 0.0 | $36k | 2.3k | 15.77 | |
| Cullinan Oncology (CGEM) | 0.0 | $31k | 3.0k | 10.35 | |
| Generation Bio Com New (GBIO) | 0.0 | $31k | 5.4k | 5.68 | |
| Eledon Pharmaceuticals (ELDN) | 0.0 | $9.1k | 6.0k | 1.51 | |
| Vir Biotechnology (VIR) | 0.0 | $1.2k | 200.00 | 6.03 |
